Sinopia Biosciences

San Diego, United States

Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

Mar 2026

Grant

Artificial Intelligence (AI)Biopharma Biotechnology Machine Learning Neuroscience

Top Investors

Michael J. Fox FoundationNational Cancer InstituteNational Institute of Neurological Disorders and StrokeNational HeartLung and Blood InstituteNational Institute of General Medical Science

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sinopia Biosciences

Who are Sinopia Biosciences's investors?

Sinopia Biosciences's investors include Michael J. Fox Foundation, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Heart, Lung and Blood Institute, National Institute of General Medical Science.

Where is Sinopia Biosciences headquartered?

Sinopia Biosciences is headquartered in San Diego, United States.

What does Sinopia Biosciences do?

Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

What stage is Sinopia Biosciences at?

Sinopia Biosciences is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2026.

MLA

"Sinopia Biosciences — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/sinopia-biosciences. Accessed July 1, 2026.

APA

VCBacked. (2026). Sinopia Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/sinopia-biosciences

Wikipedia (cite web)

{{cite web |title=Sinopia Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/sinopia-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2026.